Bausch + Lomb announced the acquisition of the ELIOS system, a laser-based technology that offers a new approach to treating ...

Bausch + Lomb announced today that an affiliate acquired Elios Vision, developer of a minimally invasive glaucoma surgery ...

Iantrek’s CREST Registry reports 1-year outcomes for a bio-interventional glaucoma treatment, demonstrating significant IOP ...

Advanced tools are being deployed by Duke Health and others in the fight against vision loss. STORY HIGHLIGHTS Half of ...

The potential for optometrists to monitor glaucoma in community practice was the subject of a presentation by Professor ...

Bausch + Lomb Corporation (BLCO) has released an update.Pick the best stocks and maximize your portfolio:Discover top-rated stocks from highly ...

ViaLase, Inc., a clinical-stage medical technology company focused on addressing unmet needs in the conventional glaucoma ...

OT heard about the biggest milestones in Glaucoma UK’s 50-year history from chief executive of the charity, Joanne Creighton ...

The acquisition strengthens Bausch + Lomb's existing portfolio of surgical and pharmaceutical glaucoma treatments.

The US company has said that its treatment for the heart condition was generally well tolerated despite some mild adverse ...

Glaucoma is often called the “silent thief of sight” because it can damage vision without warning signs. It harms the optic ...